Zotiraciclib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Zotiraciclib, covering 2021-09-28 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations [Phase 1, Phase 2]